With a rise in precision
medicines, high value shipments and emerging shipping routes, global biopharma
industry spending on temperature-controlled products is expected to reach $15.7
billion in 2019. To ensure that companies are able to navigate this new product
landscape and complex routes in a cost efficient and effective way, they must
rely on specialised and trusted partners.
In this report, Pharma IQ explores the current development trends, and
how this will affect temperature control and logistics spending in the next 12
to 24 months.
Key benefits of downloading the full report:
Download the full report now
>>
Please note: That all fields marked with an asterisk (*) are required.